Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: An Eastern Cooperative Oncology Group Study

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 1880-1884

  Sparano, J A ^a   Neuberg, D ^a   Glick, J H ^a   Robert, N J ^a   Goldstein, L J ^a   Sledge, G W ^a   Wood, W ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CISPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; DOXORUBICIN; PACLITAXEL;

ADULT; ARTICLE; BLOOD TOXICITY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC DISORDER; METASTASIS; NEUROTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0030979432     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.1880     Document Type: Article

References (11)

1. Henderson IC: Chemotherapy for metastatic disease, in Harris J. Hellman S. Henderson IC, et al (eds): Breast Diseases. Philadelphia, PA, Lippincott, 1991, pp 604-664
2. Gelmon KA, O'Reilly S, Plenderleith IH, et al: Bi-weekly paclitaxel and cisplatin in the treatment of metastatic breast cancer. Proc Am Soc Clin Oncol 13:71, 1994 (abstr 87)
3. Gelmon KA, O'Reilly SE, Tolcher AW, et al: Phase I/II trial of biweekly paclitaxel and cisplatin in the treatment of metastatic breast cancer. J Clin Oncol 14:1185-1191, 1996
4. Ajani JA, Welch SR, Raber MN, et al: Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest 8:147-159, 1990
5. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
6. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1959
7. Cox DR: The Analysis of Binary Data. London, United Kingdom, Methuen, 1970
8. McCaskill-Stevens W, Ansari R, Fisher W, et al: Phase II study of biweekly cisplatin and paclitaxel in the treatment of metastatic breast cancer. Proc Am Soc Clin Oncol 15:120, 1996 (abstr 144)
9. Wasserheit C, Frazein A, Oratz R, et al: Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: An active regimen with limiting neurotoxicity. J Clin Oncol 14:1993-1999, 1996
10. Berry J, Ezzat A, El-Warith A, et al: Sequential Taxol/platinum: Pilot study in metastatic breast cancer. Proc Am Soc Clin Oncol 14:136, 1995 (abstr 243)
11. Brown MJ, Kennedy T, Cummings F, et al: Phase II study of Taxol and cisplatin for the treatment of metastatic breast cancer. Proc Am Soc Clin Oncol 14:136, 1995 (abstr 245)